- M Science has received approval for a Type 4 License in Hong Kong, permitting the company to create and distribute its proprietary research locally
- Industry veterans Bruce Ingram and Jonathan Sleath will lead the new Asia-Pacific initiative; Additional China-focused product launches planned for H1
- M Science continues to build momentum as a market leader and deliver on their fifteen year legacy of excellence and customer service
NEW YORK & HONG KONG–(BUSINESS WIRE)–M Science, the pioneer in data-driven research and analytics, today announced that M Science Hong Kong Limited has received its Type 4 License (Advising on Securities) from the Securities and Futures Commission of Hong Kong. The license coincides with M Science’s establishment of a Hong Kong office to provide data driven research and analytics to professional investors in the region.
M Science Hong Kong Limited will be led by two senior industry veterans: Bruce Ingram, who joins from Jefferies where he was a managing director and head of Asia equity sales, and Jonathan Sleath, from Investec Capital Asia Limited where he was an investment director. The pair will focus on building a local Asia-Pacific sales team, as well as client service, data sourcing, research and analytics functions.
“Our expansion in Asia reflects both growing client demand and a growing product suite designed for international markets,” said Michael Marrale, CEO of M Science. “We have a fifteen-plus year legacy of building trust with our clients given our leading position as an innovator and strong focus on data diligence and compliance. This is a milestone in our growth strategy and we are fortunate to have experts like Bruce and Jonathan to build our presence locally and serve our Asia clients.”
Utilizing our unique data methodology and expertise, M Science provides institutional investors with written research and analytics on Chinese public companies like Alibaba, Bilibili, Tencent, Pinduoduo Group, NetEase and insights across sectors like e-commerce, online gaming, online streaming and education. Additionally, M Science has mapped the entire global handset supply chain and provides market leading insight on 5G device adoption, an area of particular focus for our Asia-Pacific clients. Further expansion of our product suite in the coming months will help serve increasing customer demand in the region.
“We look forward to serving our growing client-base with exceptional intelligence and expanding product offerings in support of the new Hong Kong office and teammates,” said Henry Guo and Sunny Wu, senior analysts at M Science, covering China Internet and E-Commerce sectors.
About M Science
M Science is a data-driven research and analytics firm, uncovering new insights for leading financial institutions and corporations. M Science is revolutionizing research, discovering new data sets and pioneering methodologies to provide actionable intelligence. Our research teams have decades of experience working with unstructured data in near real-time to discern critical insights that help clients make smarter, more informed decisions. We combine the best of finance, data and technology to create a truly unique value proposition for both financial services firms and major corporations in a variety of industries.
M Science is a portfolio company of Leucadia Investments, a division of Jefferies Financial Group Inc. (NYSE: JEF) with offices in New York, London, Hong Kong and Portland, Oregon. For more information, please visit www.mscience.com.
Ryan J. Walker
R. J. Walker & Co.
860 930 3611